Virtual US Symposium
Clinically-Relevant Tumor Models for Cancer Drug Discovery and Development
Attend this symposium to explore:
- The role of modeling clinical resistance in the development of new anticancer agents
- How new, translational platforms such as tumor organoids are used to evaluate CAR-T cell therapies
- The latest breakthroughs in humanized mouse models
Who should attend?
Speakers: Sylvia Boj (CSO HUB), Anthony Tolcher (CEO NEXT Oncology), Gerold Feuer (Feuer Consulting Services), Fiore Cattaruzza (Amunix Pharmaceuticals), Dean Campbell (Crown Bioscience)
Date: Wednesday, December 9
Time: 9 AM PST
Register now: Virtual US Symposium
February 05, 2021
Laboratory Animal Sciences 2021
LabRoots is pleased to announce the 10th Annual Laboratory Animal Science Virtual Conference which will take place on Fe...
read more
September 04, 2020
HUB and BGI-Qingdao sign a Memorandum of Unde...
Utrecht and Qingdao, Sep 4th, 2020 – Hubrecht Organoid Technology (HUB) and BGI-Qingdao announced today that they ...
read more